Trial Profile
A Cancer Research UK Phase I/IIa Clinical Trial of BT1718, (A Bicycle Drug Conjugate) Given Intravenously in Patients With Advanced Solid Tumours
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Feb 2024
Price :
$35
*
At a glance
- Drugs BT 1718 (Primary)
- Indications Advanced breast cancer; Non-small cell lung cancer; Oesophageal cancer; Sarcoma; Solid tumours; Squamous cell cancer
- Focus Adverse reactions; First in man
- 06 Feb 2024 Status changed from active, no longer recruiting to completed.
- 20 Mar 2023 Status changed from recruiting to active, no longer recruiting.
- 16 Aug 2022 Planned End Date changed from 31 Mar 2022 to 4 Dec 2024.